Inhibition of microRNA-34c reduces detrusor ROCK2 expression and urinary bladder inflammation in experimental...

Area of Science:

• Urology
• Molecular Biology
• Immunology

Background:

• Interstitial cystitis (IC), also known as painful bladder syndrome (PBS), is a chronic condition characterized by bladder inflammation, disproportionately affecting women.
• The precise cause and pathogenesis of IC remain largely unknown, necessitating further research into underlying molecular mechanisms.

Purpose of the Study:

• To investigate the role of microRNAs (miRs) in the pathogenesis of cyclophosphamide (CYP)-induced cystitis.
• To identify specific miRs involved in bladder inflammation and smooth muscle function and evaluate their therapeutic potential.

Main Methods:

• Utilized a cyclophosphamide (CYP)-induced mouse model to simulate cystitis.
• Performed histological evaluation of urinary bladder (UB) tissue to assess inflammation.
• Employed ELISA and real-time PCR (RT-PCR) to analyze inflammatory markers and differentially expressed miRs.

Main Results:

• CYP-induced cystitis exhibited significant immune cell infiltration, elevated inflammatory scores, and altered expression of eight specific miRs in UB cells.
• miR-34c was identified as a key regulator, with its inhibition reducing inflammatory signaling (STAT3, TGF-β1, VEGF) and modulating ROCK1/ROCK2 expression.
• Blocking miR-34c ex vivo demonstrated a suppressive effect on inflammatory responses in the urinary bladder.

Conclusions:

• miR-34c plays a critical role in regulating inflammatory signaling pathways in cystitis.
• Targeting miR-34c presents a promising therapeutic strategy for mitigating inflammation in IC.
• miR-34c may serve as a potential biomarker for cystitis diagnosis and treatment monitoring.